JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Accepted Preprint first posted online on 21 May 2008

Journal of Endocrinology 2008;198:419.

Journal of Endocrinology (2008) In press
DOI: 10.1677/JOE-08-0022
© 2008 Society for Endocrinology
This Article
Right arrow Accepted manuscript (PDF)
Right arrow All Versions of this Article:
JOE-08-0022v1
198/2/419    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reini, S.
Right arrow Articles by Keller-Wood, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reini, S.
Right arrow Articles by Keller-Wood, M.

RESEARCH

Cardiac corticosteroid receptors receptors mediate the enlargement of the ovine fetal heart induced by chronic increases in maternal cortisol

Seth Reini, Garima Dutta, Charles Wood and Maureen Keller-Wood

S Reini, Department of Physiology and Functional Genomics, University of Florida, Gainesville, United States
G Dutta, Department of Pharmacodynamics, University of Florida, gainesville, United States
C Wood, Department of Physiology and Functional Genomics, University of Florida, Gainesville, United States
M Keller-Wood, Department of Pharmacodynamics, University of Florida, Gainesville, United States

Correspondence: Maureen Keller-Wood, Email: kellerwd{at}cop.ufl.edu

Abstract

Previous studies have demonstrated that modest, physiologically relevant increases in maternal cortisol in late gestation result in enlargement of the fetal heart. In this study, we investigated the role of mineralocorticoid (MR) or glucocorticoid receptor (GR) in this enlargement. Ewes with single fetuses were randomly assigned at ~ 120d gestation to one of four groups: maternal cortisol infusion (1mg kg-1 day-1, cortisol); maternal cortisol infusion with fetal intrapericardial infusion of the MR antagonist potassium canrenoate (600µg day-1; cortisol + MRa); maternal cortisol infusion with fetal intrapericardial infusion of the GR antagonist mifepristone (50µg day-1, cortisol + GRa); and maternal saline infusion (control). At ~130 days gestation, fetal heart to body weight ratio and right (RV) and left ventricular (LV) free wall thickness were increased in the cortisol group compared to control group. Fetal hearts from the cortisol +MRa group weighed significantly less, with thinner LV, RV and interventricular septum walls, compared to the cortisol group. Fetal hearts from the cortisol + GRa group had significantly thinner RV walls than the cortisol group. Fetal arterial pressure and heart rate were not different among groups at 130 days. Picrosirius red staining of fetal hearts indicated that the increased size was not accompanied by cardiac fibrosis. These results suggest that physiologic increases in maternal cortisol late in gestation induce fetal cardiac enlargement via MR and, to a lesser extent, by GR, and indicate the enlargement is not secondary to an increase in fetal blood pressure or an increase in fibrosis within the fetal heart.




This article has been cited by other articles:


Home page
HypertensionHome page
A. C. Montezano and R. M. Touyz
Networking Between Systemic Angiotensin II and Cardiac Mineralocorticoid Receptors
Hypertension, December 1, 2008; 52(6): 1016 - 1018.
[Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Society for Endocrinology.